Progyny, Inc. Proceeds from Sale and Maturity of Marketable Securities
Progyny, Inc. (PGNY) reported Proceeds from Sale and Maturity of Marketable Securities of $107.08 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-08.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities · last filed 2021-11-08
- Progyny, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-09-30 was $30.09M.
- Progyny, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-06-30 was $52.99M.
- Progyny, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2021-03-31 was $24.00M.
- Progyny, Inc. proceeds from sale and maturity of marketable securities for the quarter ending 2020-12-31 was $50.97M.
- Progyny, Inc. proceeds from sale and maturity of marketable securities for fiscal 2020 was $64.97M.
| Period end | Proceeds from Sale and Maturity of Marketable Securities 3 month | Proceeds from Sale and Maturity of Marketable Securities 6 month | Proceeds from Sale and Maturity of Marketable Securities 9 month | Proceeds from Sale and Maturity of Marketable Securities 12 month |
|---|---|---|---|---|
| 2021-09-30 | $30.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $83.08M derived: sum of 2 quarters · filed 2021-11-08 | $107.08M 10-Q · filed 2021-11-08 | $158.05M derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | $52.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $76.98M 10-Q · filed 2021-08-06 | $127.95M derived: sum of 3 quarters · filed 2021-08-06 | |
| 2021-03-31 | $24.00M 10-Q · filed 2021-05-07 | $74.97M derived: sum of 2 quarters · filed 2021-05-07 | ||
| 2020-12-31 | $50.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $64.97M 10-K · filed 2021-03-01 | ||
| 2020-09-30 | $14.00M 10-Q · filed 2021-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |